IFIH1 and dermatomyositis: The subgroup of inflammatory myopathies, anti‐melanoma differentiation‐associated gene 5 antibody‐positive dermatomyositis (anti‐MDA5 DM), is particularly associated with ILD, affecting over 80% of patients [4, 5, 6], whereas muscular signs may be secondary or even absent.